Elizabeth Arden Rating Increased to Neutral at Zacks (RDEN)
Elizabeth Arden (NASDAQ:RDEN) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a report issued on Tuesday, ARN reports. The firm currently has a $37.90 price objective on the stock. Zacks‘ price target points to a potential upside of 2.46% from the company’s current price.
RDEN has been the subject of a number of other recent research reports. Analysts at SunTrust upgraded shares of Elizabeth Arden from a “neutral” rating to a “buy” rating in a research note to investors on Tuesday, September 24th. They now have a $50.00 price target on the stock, up previously from $35.00. They noted that the move was a valuation call. Separately, analysts at B. Riley downgraded shares of Elizabeth Arden from a “buy” rating to a “neutral” rating in a research note to investors on Wednesday, September 18th. They now have a $40.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at BMO Capital Markets cut their price target on shares of Elizabeth Arden from $46.00 to $36.00 in a research note to investors on Friday, August 9th. They now have a “market perform” rating on the stock. Six investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $42.27.
Shares of Elizabeth Arden (NASDAQ:RDEN) traded down 1.00% during mid-day trading on Tuesday, hitting $36.62. 52,988 shares of the company’s stock traded hands. Elizabeth Arden has a one year low of $30.37 and a one year high of $49.75. The stock’s 50-day moving average is $35.71 and its 200-day moving average is $41.56. The company has a market cap of $1.084 billion and a P/E ratio of 27.81.
Elizabeth Arden (NASDAQ:RDEN) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.10 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.33 by $0.23. The company had revenue of $267.60 million for the quarter, compared to the consensus estimate of $289.86 million. During the same quarter in the prior year, the company posted $0.28 earnings per share. The company’s quarterly revenue was up .8% on a year-over-year basis.
Elizabeth Arden, Inc is a beauty products company with a range of portfolio of fragrance, skin care and cosmetics brands.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.